Clin2
NCT07041359Possibly a fitRecruiting

Traditional Chinese medicine for elderly heart disease patients with ongoing symptoms

Coronary Arterial Disease (CAD)

Part of Heart & circulation clinical trials.

This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
120 people
Ages
75 years to 90 years
Study type
Interventional

Who can take part

  • You are between 75 and 89 years old.
  • You have chest discomfort (angina) triggered by activity or stress, which gets better with rest or nitroglycerin, and standard Western medicine hasn't helped enough.
  • You have at least two heart arteries with significant blockage (over 50%), and you either can't have or have already had partial angioplasty/stents with some blockage remaining.
  • Your traditional Chinese medicine diagnosis is either qi stagnation with blood stasis or qi deficiency with blood stasis.
  • You can communicate well and are willing to sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06880575Recruiting
Registry for seniors with coronary heart disease (SILVER-China)

This registry study in China is following older adults (75+) with coronary heart disease to learn more about their health over time. It involves sharing your medical information and coming back for check-ups, but no experimental treatments are given.

Beijing, Beijing Municipality
NCT07445581Not yet recruiting
Tanhuo Decoction for seniors with heart and brain artery issues

This trial tests a traditional Chinese herbal formula, Tanhuo Decoction, for elderly patients who recently had a heart attack (acute coronary syndrome) and also have brain artery narrowing or a history of stroke. It aims to see if the medicine helps improve recovery and reduce future risks.

Beijing, Beijing Municipality
NCT06901570Not yet recruiting· Phase 4
Aromatic Wentong for heart small vessel disease

This trial tests a Chinese herbal medicine called Aromatic Wentong for people with coronary microvascular disease—a condition where the tiny blood vessels in the heart don't work properly, causing chest pain. The medicine may help improve blood flow in the small vessels.

Beijing, Chaoyang District
NCT05309343Recruiting
Traditional Chinese medicine study for heart disease patients

This study follows people who are being admitted for heart and blood vessel conditions and records their standard (Western) heart diagnoses. The goal is to describe how traditional Chinese medicine is used for these conditions and what diagnoses the people have.

Tianjin
NCT06669169Not yet recruiting· Phase 2
Jia Shen tablets for chronic heart failure

This trial tests whether Jia Shen tablets, a traditional Chinese medicine, can help people with chronic heart failure due to coronary heart disease. It aims to improve symptoms and quality of life.

Tianjin, Tianjin Municipality
NCT05583773Recruiting· Phase 4
Herbal medicine for heart failure with lower pumping strength

This trial tests SHengXIaN-QuYu decoction (an herbal treatment) in people with symptomatic heart failure and reduced pumping function. It looks to see whether the herbal formula is safe and helpful for heart failure symptoms and heart function.

Beijing, Beijing Municipality

Hear when a new Coronary Arterial Disease (CAD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.